Scarica l'app Stockscreener
95.23
0.49%
0.525
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$94.71
Aprire:
$94.91
Volume 24 ore:
86,788
Relative Volume:
0.06
Capitalizzazione di mercato:
$18.83B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
23.19
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-3.70%
1M Prestazione:
-7.67%
6M Prestazione:
-7.02%
1 anno Prestazione:
-8.05%
Intervallo 1D:
$94.55
$95.49
Intervallo di 1 settimana:
$94.55
$99.86
Portata 52W:
$89.24
$114.72
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.08 | 18.76B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
131.27 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.70 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
365.51 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.10 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.16 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Will Zimmer Biomet Holdings Inc. see short term momentumMarket Movers & Safe Entry Point Alerts - newser.com
Candlestick signals on Zimmer Biomet Holdings Inc. stock todayCPI Data & Accurate Entry and Exit Point Alerts - newser.com
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain institutional flowsChart Signals & Reliable Price Action Trade Plans - newser.com
Matrix Asset Advisors Inc. NY Lowers Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Q3 Earnings To Highlight Innovation And GrowthWhy I Think It's A Buy - Seeking Alpha
Analyzing drawdowns of Zimmer Biomet Holdings Inc. with statistical tools2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Costello Asset Management INC Sells 6,560 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Stock Position Raised by Callan Family Office LLC - MarketBeat
RBC Trims Price Target on Zimmer Biomet Holdings to $111 From $115, Keeps Outperform Rating - MarketScreener
Custom watchlist performance reports with Zimmer Biomet Holdings Inc.Market Activity Summary & Community Consensus Stock Picks - newser.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Truist Financial Corp - MarketBeat
Zimmer Biomet launches foot, ankle trauma systems - MassDevice
Tag Archives: foot and ankle trauma - InkFreeNews.com
Zimmer Biomet Launches Foot, Ankle Solutions For Complex Trauma Cases - InkFreeNews.com
Market reaction to Zimmer Biomet Holdings Inc.’s recent newsDollar Strength & Low Drawdown Momentum Ideas - newser.com
Is Zimmer Biomet Holdings Inc. stock attractive after correctionAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Is Zimmer Biomet Holdings Inc ZIM a good long term investmentStock Price Divergence & Small Investment Portfolio Tips - earlytimes.in
Identifying reversal signals in Zimmer Biomet Holdings Inc.Weekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Janney Montgomery Scott LLC Acquires 9,482 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet's (ZBH) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Zimmer Biomet Completes Acquisition Of Orthopedic Robotics Company - InkFreeNews.com
Zimmer Biomet closes acquisition of Monogram Technologies - MSN
Zimmer Biomet launches new solutions for complex foot and ankle trauma - Investing.com Canada
Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions - Nasdaq
Two trauma devices: Zimmer Biomet launches Gorilla Pilon Fusion & Phantom TTC Nail — US launch - Stock Titan
Robeco Institutional Asset Management B.V. Sells 10,504 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Secured Retirement Advisors LLC Invests $413,000 in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies - MarketScreener
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio - MassDevice
Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Tech - GuruFocus
Zimmer Biomet Acquires Monogram Orthopaedics on October 7, 2025 - TipRanks
Zimmer Biomet Acquires Monogram Technologies to Enhance Robotics - TipRanks
Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc.. - MarketScreener
Evercore ISI Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00 - MarketBeat
What analysts say about Zimmer Biomet Holdings Inc ZIM stockPrice-to-Earnings Ratio Insights & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Oct. 7Zimmer Biomet acquires AI-robotics orthopedic company Monogram Technologies - Fort Wayne Business Weekly
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M - GuruFocus
Evercore ISI Adjusts Zimmer Biomet Price Target to $104 From $106, Maintains In Line Rating - MarketScreener
Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies - GuruFocus
Does Japan’s Approval of Iodine Hip Implants Alter the Bull Case for Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet Completes Acquisition of Monogram Technologies - WV News
Zimmer Biomet completes acquisition of Monogram Technologies - Investing.com
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Analysts - MarketBeat
Will Japan’s Approval of Iodine Hip Implants Redefine Zimmer Biomet Holdings' (ZBH) Infection Prevention Narrative? - Sahm
How Zimmer Biomet Holdings Inc. stock valuation compares with sectorJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance - Yahoo Finance
Zimmer Biomet (ZBH): Valuation Spotlight After Japan Approves Innovative Infection-Resistant Hip Implants - Yahoo Finance
Published on: 2025-10-06 04:10:48 - newser.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results - BioSpace
Greenleaf Trust Lowers Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):